Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases

BACKGROUND: Salvage treatment for recurrent brain metastases (BM) of solid cancers is challenging due to the high symptomatic burden and the limited local treatment options. METHODS: Patients with recurrent BM with no option for further local therapies were retrospectively identified from BM databas...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghoff, Anna Sophie, Breckwoldt, Michael Oliver, Riedemann, Lars, Karimian-Jazi, Kianush, Loew, Sarah, Schlieter, Franziska, Furtner, Julia, Cinci, Marc, Thomas, Michael, Strowitzki, Moritz J, Marmé, Frederik, Michel, Laura L, Schmidt, Thomas, Jäger, Dirk, Bendszus, Martin, Preusser, Matthias, Wick, Wolfgang, Winkler, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212911/
https://www.ncbi.nlm.nih.gov/pubmed/32642693
http://dx.doi.org/10.1093/noajnl/vdaa038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212911/
https://www.ncbi.nlm.nih.gov/pubmed/32642693
http://dx.doi.org/10.1093/noajnl/vdaa038

Ejemplares similares